Effect of platelet-activating factor antagonist BN 52063 on the nephrotoxicity of cisplatin

Oscar F. Pavão dos Santos; Mirian A. Boim; Elivo J. G. Barros; Eduardo Pirotzky; Pierre Braquet; Nestor Schor

doi:10.1007/bf02536558

Effect of platelet-activating factor antagonist BN 52063 on the nephrotoxicity of cisplatin

Lipids ◽

10.1007/bf02536558 ◽

1991 ◽

Vol 26 (12) ◽

pp. 1324-1328 ◽

Cited By ~ 6

Author(s):

Oscar F. Pavão dos Santos ◽

Mirian A. Boim ◽

Elivo J. G. Barros ◽

Eduardo Pirotzky ◽

Pierre Braquet ◽

...

Keyword(s):

Platelet Activating Factor ◽

Factor Antagonist

Download Full-text

Der Platelet-Activating Factor Antagonist WEB-2170 hemmt die Lipopolysaccharid-induzierte vorzeitige Reifung der uterinen Zervix

Zeitschrift für Geburtshilfe und Neonatologie ◽

10.1055/s-2003-818150 ◽

2004 ◽

Vol 207 (S 2) ◽

Author(s):

H Maul ◽

J Weichert ◽

HH Günter ◽

L Shi ◽

RE Garfield ◽

...

Keyword(s):

Platelet Activating Factor ◽

Factor Antagonist

Download Full-text

Alterations in endocardial vascular resistance after reperfusion in a low flow, high demand model of ischemia: effects of dipyridamole and WEB-2086, a platelet-activating factor antagonist

Journal of the American College of Cardiology ◽

10.1016/0735-1097(90)90330-r ◽

1990 ◽

Vol 16 (7) ◽

pp. 1750-1759 ◽

Cited By ~ 2

Author(s):

Erwin Schröder ◽

Hubert Pouleur ◽

Henri Van Mechelen ◽

André Keyeux ◽

Juan Raigoso ◽

...

Keyword(s):

Vascular Resistance ◽

Platelet Activating Factor ◽

Low Flow ◽

Demand Model ◽

High Demand ◽

Factor Antagonist ◽

Web 2086

Download Full-text

The effect of the orally active platelet-activating factor antagonist WEB 2086 in the treatment of asthma.

American Journal of Respiratory and Critical Care Medicine ◽

10.1164/ajrccm.149.5.8173754 ◽

1994 ◽

Vol 149 (5) ◽

pp. 1142-1148 ◽

Cited By ~ 65

Author(s):

D P Spence ◽

S L Johnston ◽

P M Calverley ◽

P Dhillon ◽

C Higgins ◽

...

Keyword(s):

Platelet Activating Factor ◽

Orally Active ◽

Factor Antagonist ◽

Web 2086

Download Full-text

Cmi-206: A potent dual platelet activating factor antagonist and 5-lipoxygenase inhibitor

Bioorganic & Medicinal Chemistry Letters ◽

10.1016/0960-894x(95)00088-b ◽

1995 ◽

Vol 5 (6) ◽

pp. 643-648 ◽

Cited By ~ 2

Author(s):

Md. Sajjat Hussoin ◽

Xiong Cai ◽

Ralph T. Scannell ◽

David Yaeger ◽

David B. Killian ◽

...

Keyword(s):

Platelet Activating Factor ◽

Lipoxygenase Inhibitor ◽

Factor Antagonist

Download Full-text

Determination of the platelet activating factor antagonist 6-(2-chlorophenyl)-9-[(4-methoxyphenyl)thiocarbamoyl]-1-methyl-7,8,9,10-tetrahydro-4H-pyrido[4′,3′-4,5]-thieno[3,2-f][1,2,4]triazolo [4,3-a][1,4] diazepine in human plasma by liquid chromatography—thermospray mass spectrometry

Journal of Chromatography B Biomedical Sciences and Applications ◽

10.1016/0378-4347(94)80090-1 ◽

1994 ◽

Vol 657 (1) ◽

pp. 214-218

Author(s):

C. Celma

Keyword(s):

Mass Spectrometry ◽

Liquid Chromatography ◽

Human Plasma ◽

Platelet Activating Factor ◽

Thermospray Mass Spectrometry ◽

Factor Antagonist

Download Full-text

A platelet-activating factor antagonist, RP 55778, inhibits cytokine-dependent induction of human immunodeficiency virus expression in chronically infected promonocytic cells.

Proceedings of the National Academy of Sciences ◽

10.1073/pnas.90.6.2537 ◽

1993 ◽

Vol 90 (6) ◽

pp. 2537-2541 ◽

Cited By ~ 22

Author(s):

D. Weissman ◽

G. Poli ◽

A. Bousseau ◽

A. S. Fauci

Keyword(s):

Human Immunodeficiency Virus ◽

Platelet Activating Factor ◽

Immunodeficiency Virus ◽

Virus Expression ◽

Factor Antagonist ◽

Promonocytic Cells

Download Full-text

Double blind, randomised, placebo controlled study of a platelet activating factor antagonist, lexipafant, in the treatment and prevention of organ failure in predicted severe acute

Gut ◽

10.1136/gut.48.1.62 ◽

2001 ◽

Vol 48 (1) ◽

pp. 62-69 ◽

Cited By ~ 224

Author(s):

C D Johnson

Keyword(s):

Organ Failure ◽

Platelet Activating Factor ◽

Controlled Study ◽

Double Blind ◽

Treatment And Prevention ◽

Factor Antagonist

Download Full-text

Antagonism of endotoxin-induced disruption of equine gastrointestinal motility with the platelet-activating factor antagonist WEB 2086

Journal of Veterinary Pharmacology and Therapeutics ◽

10.1111/j.1365-2885.1990.tb00786.x ◽

1990 ◽

Vol 13 (4) ◽

pp. 333-339 ◽

Cited By ~ 18

Author(s):

J. N. KING ◽

E. L. GERRING

Keyword(s):

Gastrointestinal Motility ◽

Platelet Activating Factor ◽

Factor Antagonist ◽

Web 2086

Download Full-text

Metabolism of the platelet-activating factor antagonist (±)-trans-2-(3′-methoxy-5′-methylsulphonyl-4′-propoxyphenyl)-5-(3″, 4″,5″-trimethoxyphenyl)tetrahydrofuran (L-659,989) in rhesus monkeys

Xenobiotica ◽

10.3109/00498259109039501 ◽

1991 ◽

Vol 21 (5) ◽

pp. 613-625 ◽

Cited By ~ 4

Author(s):

K. L. Thomson ◽

M. N. Chang ◽

R. L. Bugianesi ◽

M. M. Ponpipom ◽

B. H. Arison ◽

...

Keyword(s):

Rhesus Monkeys ◽

Platelet Activating Factor ◽

Factor Antagonist

Download Full-text

THE PLATELET-ACTIVATING FACTOR ANTAGONIST WEB 2170 ITS BENEFICIAL EFFECT ON DOG RENAL ALLOGRAFT SURVIVAL

Transplantation Journal ◽

10.1097/00007890-199310000-00047 ◽

1993 ◽

Vol 56 (4) ◽

pp. 1047-1048 ◽

Cited By ~ 1

Author(s):

CHRISTOPHER J. E. WATSON ◽

ROGER LUDDINGTON ◽

D. G. ST. JOHN COLLIER ◽

ROY Y. CALNE ◽

SUSAN M. METCALFE

Keyword(s):

Beneficial Effect ◽

Renal Allograft ◽

Platelet Activating Factor ◽

Allograft Survival ◽

Factor Antagonist

Download Full-text